Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8982503 | 0.81 | PDE4A (0.32) | CYP3A4TDP1HSD11B1AR | |
| SCHEMBL19009972 | 0.76 | HSD11B1 (0.30) | HSD11B1 | |
| SCHEMBL19009982 | 0.72 | ALDH1A1 (0.39) | CYP3A4TDP1 | |
| SCHEMBL4205832 | 0.72 | ALDH1A1 (0.39) | CYP3A4TDP1 | |
| SCHEMBL15658814 | 0.71 | TDP1 (0.39) | CYP3A4TDP1HSD11B1 | |
| SCHEMBL15660678 | 0.71 | CYP3A4 (0.39) | CYP3A4TDP1HSD11B1 | |
| SCHEMBL10792614 | 0.70 | TDP1 (0.46) | CYP3A4TDP1HSD11B1AR | |
| SCHEMBL30085602 | 0.70 | TDP1 (0.46) | CYP3A4TDP1HSD11B1AR | |
| SCHEMBL8168777 | 0.69 | TDP1 (0.41) | CYP3A4TDP1 | |
| SCHEMBL12880845 | 0.69 | ALDH1A1 (0.32) | CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3199513-B1 | PROCESS FOR PRODUCING ALCOHOL ANALOGUE | TAKASAGO PERFUMERY CO LTD (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-10029968-B2 | Process for producing alcohol analogue | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-07-24 | — | — | US | disclosed |
| US-20170297990-A1 | PROCESS FOR PRODUCING ALCOHOL ANALOGUE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-10-19 | — | — | US | disclosed |
| EP-3199513-A1 | PROCESS FOR PRODUCING ALCOHOL ANALOGUE | Takasago International Corporation (JP) | 2017-08-02 | — | — | EP | disclosed |
| EP-2762467-B1 | Method for producing an optically active 2-arylpiperidinium salt | TAKASAGO PERFUMERY CO LTD (JP) | 2016-08-03 | — | — | EP | disclosed |
| EP-2611819-B1 | IRIDIUM COMPLEX AND METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | TAKASAGO PERFUMERY CO LTD (JP) | 2015-12-16 | — | — | EP | disclosed |
| US-9012649-B2 | Method for producing optically active 2-arylpiperidinium salt | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-04-21 | — | — | US | disclosed |
| EP-2762467-A1 | Method for producing an optically active 2-arylpiperidinium salt | Takasago International Corporation (JP) | 2014-08-06 | — | — | EP | disclosed |
| US-20140213792-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 2-ARYLPIPERIDINIUM SALT | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-07-31 | — | — | US | disclosed |
| EP-1698609-B1 | Process for producing an alcohol or its silyl ether | TAKASAGO PERFUMERY CO LTD (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-20090299076-A1 | Axially asymmetric ester compound and production method thereof | NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090227805-A1 | Axially Asymmetric Phosphorus Compound and Production Method Thereof | NATIONAL UNIVERSITY OF CORPORATION TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY (JP) | 2009-09-10 | — | — | US | disclosed |
| EP-2098531-A1 | Axially asymmetric phosphorus compound and production method thereof | National University Corporation Tokyo University of Agriculture and Technology (JP) | 2009-09-09 | — | — | EP | disclosed |
| US-20090221851-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINOPHOSPHINYLBUTANOIC ACIDS | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2009-09-03 | — | — | US | disclosed |
| EP-2060578-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINOPHOSPHINYLBUTANOIC ACID | MEIJI SEIKA KAISHA LTD. (JP) | 2009-05-20 | — | — | EP | disclosed |
| US-20090036696-A1 | IRIDIUM COMPLEXES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| EP-1935896-A1 | Novel optically active biaryl phosphorus compound and production process thereof | National University Corporation Tokyo University of Agriculture and Technology (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-20080139822-A1 | Novel optically active biaryl phosphorus compound and production process thereof | MAXWELL TECHNOLOGIES, INC. | 2008-06-12 | — | — | US | disclosed |
| EP-1698609-A1 | Process for producing an alcohol or its silyl ether | Takasago International Corporation (JP) | 2006-09-06 | — | — | EP | disclosed |
| US-5686616-A | Process for preparing an optically active amine | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1997-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036696-A1 | IRIDIUM COMPLEXES | HAX1, MLX, H1-0 | CYP3A4 137/4885TDP1 3327/4885HSD11B1 568/4885 |
| US-20090299076-A1 | Axially asymmetric ester compound and production method thereof | SQLE, COASY, TBC1D5 | CYP3A4 260/4885TDP1 4810/4885HSD11B1 149/4885 |
| US-20090227805-A1 | Axially Asymmetric Phosphorus Compound and Production Method Thereof | BCL2L10, BCL2A1, SOST | CYP3A4 2111/4885TDP1 3393/4885HSD11B1 1978/4885 |
| US-20090221851-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINOPHOSPHINYLBUTANOIC ACIDS | AGPS, AASDHPPT, ALAD | CYP3A4 464/4885TDP1 4270/4885HSD11B1 414/4885 |
| US-20080139822-A1 | Novel optically active biaryl phosphorus compound and production process thereof | PHOSPHO1, DHRS9, HDHD5 | CYP3A4 1590/4885TDP1 3914/4885HSD11B1 852/4885 |
| US-20170297990-A1 | PROCESS FOR PRODUCING ALCOHOL ANALOGUE | ADH1A, ADH1C, ADH5 | CYP3A4 523/4885TDP1 4077/4885HSD11B1 170/4885 |
| US-20140213792-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 2-ARYLPIPERIDINIUM SALT | REN, KCNH3, KCNH2 | CYP3A4 1499/4885TDP1 3727/4885HSD11B1 1536/4885 |
| US-10029968-B2 | Process for producing alcohol analogue | ADH1A, ADH1C, ADH5 | CYP3A4 523/4885TDP1 4077/4885HSD11B1 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.